[High-risk factors for early failure of high-flow nasal cannula oxygen therapy in children]

Area of Science:

• Pediatric Critical Care Medicine
• Respiratory Therapy
• Clinical Pediatrics

Background:

• Acute respiratory insufficiency (ARI) in children presents a significant clinical challenge.
• High-flow nasal cannula (HFNC) oxygen therapy is a common intervention for pediatric ARI.
• Identifying predictors of HFNC failure is crucial for timely escalation of care.

Purpose of the Study:

• To identify high-risk factors associated with early failure of HFNC oxygen therapy in pediatric patients with ARI.
• To inform clinical decision-making regarding respiratory support in critically ill children.

Main Methods:

• Retrospective review of clinical data from 123 children with ARI treated with HFNC.
• Classification of patients into HFNC success and early HFNC failure groups based on respiratory support escalation.
• Multivariate logistic regression analysis to determine independent risk factors for early HFNC failure.

Main Results:

• Early HFNC failure was associated with higher incidences of shock, sepsis, intracranial hypertension, and multiple organ dysfunction syndrome.
• Patients in the early failure group had lower Glasgow Coma Scale scores, pH, and oxygenation index.
• Significantly higher Pediatric Risk of Mortality (PRISM) scores and PaCO2/PaO2 ratios were observed in the early failure group.
• PRISM score >4.5 and PaCO2/PaO2 ratio >0.64 were identified as independent predictors of early HFNC failure.

Conclusions:

• Pediatric ARI patients with a PRISM score exceeding 4.5 or a PaCO2/PaO2 ratio greater than 0.64 face a substantial risk of early HFNC failure.
• These findings aid in predicting which children may require more intensive respiratory support beyond initial HFNC therapy.